ITI Pharma and Healthcare Fund
ITI Pharma and Healthcare Fund (Direct, Growth): saplin Score 8.2/10 (Strong) among 126 Sectoral/Thematic funds. 3Y return 20.7% a year vs 14.7% category median, expense ratio 0.86%. Returns that beat most peers, but a short or weak manager record. NAV ₹20.64 on 11 Nov 2026.
Loading the full analysis…